Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-027467
Filing Date
2016-08-17
Accepted
2016-08-17 18:36:26
Documents
1
Period of Report
2016-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1552
  Complete submission text file 0000899243-16-027467.txt   3089
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address
Regnante Keith (Reporting) CIK: 0001682068 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 161839675